Observational Study of Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy
Condition: Prostate Cancer, Breast Cancer, Lung Cancer, Melanoma
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT01777802
Sponsor: Mayo Clinic
Phase:
Eligibility:
- Age: minimum 18 Years maximum N/A
- Gender: All
Inclusion Criteria:
- Hormone Refractory, Metastatic Prostate Cancer, Lung Cancer, and Melanoma or Breast Cancer
Exclusion Criteria:
- -Life expectancy of less than 3 months
View trial on ClinicalTrials.gov
{{footer-clinical-trials-navigation}}